100 episodes

Author interviews that explore the latest clinical reviews.

JAMA Clinical Reviews JAMA Network

    • Medicine

Author interviews that explore the latest clinical reviews.

    Coronavirus Disease 2019 (COVID-19) Update: PCR Testing and Shortages

    Coronavirus Disease 2019 (COVID-19) Update: PCR Testing and Shortages

    The lack of availability of COVID-19 testing has interfered with the ability to contain the spread of disease. Omai Garner, PhD, laboratory director for Clinical Microbiology in the UCLA health system, explains how PCR testing for COVID-19 works and why testing is in short supply.

    • 31 min
    Coronavirus (COVID-19) Update: Lessons Learned From The 2003 SARS Outbreak

    Coronavirus (COVID-19) Update: Lessons Learned From The 2003 SARS Outbreak

    In 2003, Toronto was the North American center for Severe Acute Respiratory Syndrome (SARS). The disease spread through the city’s hospitals before anyone knew what was happening. Dr Allison McGeer was a clinician caring for SARS patients and ultimately was infected herself. She describes her experience as a patient and provider and reviews lessons learned that might help others manage their regional COVID-19 outbreaks.
    Related:
    Supporting the Health Care Workforce During the COVID-19 Global Epidemic

    • 38 min
    Coronavirus Disease 2019 (COVID-19) Update: How the VA Is Preparing

    Coronavirus Disease 2019 (COVID-19) Update: How the VA Is Preparing

    As COVID-19 spreads, clinicians and health systems are struggling to prepare for a surge of patients. Richard Stone, MD, the US Veterans Health Administration's Executive in Charge, spoke with JAMA about how the VA health system is preparing for this public health emergency.

    • 17 min
    Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin

    Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin

    Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.

    • 17 min
    Nonalcoholic Steatohepatitis: The Primary Care Perspective

    Nonalcoholic Steatohepatitis: The Primary Care Perspective

    Nonalcoholic steatohepatitis (NASH) is becoming more frequent as the population becomes more obese. This is not a benign problem, and NASH can ultimately lead to cirrhosis and liver failure. It is thought that NASH will ultimately become the most common cause for liver transplant. NASH is usually diagnosed as an incidental finding, but once found requires careful monitoring and patient counseling. Lisa N. Kransdorf, MD, MPH, from UCLA Health in California, discusses the diagnosis and management of NASH from a primary care clinician's perspective.

    • 15 min
    The Diagnosis and Management of Primary Hyperparathyroidism

    The Diagnosis and Management of Primary Hyperparathyroidism

    Hyperparathyroidism is a fairly common disease that causes elevated calcium levels and bone depletion, resulting in fractures and kidney problems. There are medications that can effectively manage hyperparathyroidism, and in some cases surgery is indicated. Michael Yeh, MD, professor and chief of endocrine surgery at UCLA, discusses the management of hyperparathyroidism.

    • 19 min

Top Podcasts In Medicine

Listeners Also Subscribed To

More by JAMA Network